omega-n-methylarginine has been researched along with ifenprodil in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (ifenprodil) | Trials (ifenprodil) | Recent Studies (post-2010) (ifenprodil) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 685 | 10 | 207 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | ifenprodil (IC50) |
|---|---|---|---|
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.105 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.105 | |
| Histamine H1 receptor | Homo sapiens (human) | 1 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.168 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.105 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.263 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.168 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.263 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.2039 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.1519 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.263 | |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.238 | |
| 5-hydroxytryptamine receptor 2A | Bos taurus (cattle) | 0.61 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.263 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.0039 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.263 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawker, DD; Jansen Labby, K; Mataka, JJ; Silverman, RB; Trippier, PC | 1 |
1 review(s) available for omega-n-methylarginine and ifenprodil
| Article | Year |
|---|---|
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; Drug Design; Humans; Huntington Disease; Neurodegenerative Diseases; Nitric Oxide Synthase Type I; Oxidative Stress; Parkinson Disease; Protein Folding; Protein Structure, Quaternary; Proteostasis Deficiencies; Receptors, N-Methyl-D-Aspartate | 2013 |